Toxic Influences on Platelet Function

  • K. Schrör
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 14)


An acquired modification of platelet function is considered to be “toxic”, when drugs or other chemicals interfere with the haemostatic potential of platelets but are not administered with the intention to treat disturbances in hemostasis. These unwanted platelet defects might either be inhibitory and clinically result in a prolonged bleeding time or stimulatory, causing a tendency for thrombosis. Because of the complex nature of platelet physiology, most agents affect more than one mechanism and in most cases it is not yet possible to classify these and other acquired disorders of platelet function by their molecular site of action (Vermylen and Blockmans 1989). Table 1 summarizes some classes of chemicals, including ethanol, that exert toxic effects on the platelet. The more interested reader is referred to several recent reviews dealing with acquired disturbances in platelet function in more detail (Barthel 1981; Carvalho and Rao 1987; Fass et al 1987; Vermylen and Blockmans 1989; Mikhailidis et al 1990).


Platelet Function Alcohol Withdrawal Tiaprofenic Acid Ethanol Withdrawal Prolonged Bleeding Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barthel W (1981) Toxische Beeinflussung der Plättchenfunktion. Erg Exp Med 38:11–42Google Scholar
  2. Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G (1988) Increased urinary excretion of thromboxane B2 and 2,3-dinor-TXB2 in cyclosporin A nephrotoxicity. Kidney Int 34:164–174PubMedCrossRefGoogle Scholar
  3. Carvalho ACA, Rao AK (1987) Aquired qualitative platelet defects. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Lippincott Philadelphia (Hemostasis and Thrombosis, pp 750–772)Google Scholar
  4. Desai K, Owen JS, Wilson DT, Hutton RA (1986) Platelet aggregation and plasma lipoproteins in alcoholics during alcohol withdrawal. Thromb Haemostasis 55:173–177Google Scholar
  5. Deykin D, Janson P, McMahon L (1982) Ethanol potentiation of aspirin-induced prolongation of the bleeding time. New Engl J Med 306:852–854PubMedCrossRefGoogle Scholar
  6. Elmer O, Göransson G, Zoucas E (1984) Impairment of primary hemostasis and platelet function after alcohol ingestion in man. Haemostasis 14:223–228PubMedGoogle Scholar
  7. Fass RJ, Copelan EA, Brandt JT, Moeschberger ML, Ashton JJ (1987) Platelet-mediated bleeding caused by broad-spectrum penicillins. J Infect Dis 155:1242–1248PubMedCrossRefGoogle Scholar
  8. FitzGerald DJ, Cattela F, Roy L, FitzGerald GA (1988) Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 77:142–150PubMedCrossRefGoogle Scholar
  9. Grace AA, Barradas MA, Mikhailidis DP et al (1987) Cyclosporin A enhances platelet aggregation. Kidney Intern 32:889–895CrossRefGoogle Scholar
  10. Hennekens CH, Willet W, Rosmer B, Cole DS, Mayrent SL (1979) Effects of beer, wine, and liquor in coronary death. J Am Med Ass 242:1973–1974CrossRefGoogle Scholar
  11. Hillbom ME, Kangasaho M, Hjelm-Jäger M (1984) Platelet aggregation and thromboxane B2 formation after ethanol abuse: Is there a relationship to stroke? Act Neurol Scand 70:432–437CrossRefGoogle Scholar
  12. Mikhailidis DP, Barradas MA, Epemolu O, Dandona P (1987) Ethanol ingestion inhibits human whole blood impedance aggregation. Am J Clin Path 88:342–345PubMedGoogle Scholar
  13. Mikhailidis DP, Barradas MA, Jeremy JY (1990) The effect of ethanol on platelet function and vascular prostanoids. Alcohol 7:171–180PubMedCrossRefGoogle Scholar
  14. Neiman J, Curstedt T, Cronholm T (1987) Composition of platelet phosphatidylinositol and phosphatidylcholine after ethanol withdrawal. Thromb Res 46:295–301PubMedCrossRefGoogle Scholar
  15. Pikaar NA, Wedel M, van der Beck EJ et al (1987) Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis and blood lipids. Metabolism 36:538–543PubMedCrossRefGoogle Scholar
  16. Salzman EW, Rosenberg RD, Smith MH et al (1980) Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64–73PubMedCrossRefGoogle Scholar
  17. Schrör K, Seidel H, Neuhaus V (1985) Potent and long-lasting inhibition of human serum thromboxane formation by tiaprofenic acid. New Trends Rheumatol 3:19–30Google Scholar
  18. Seyberth H-W, Oelz O, Kennedy T (1975) Increased arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis. Clin Pharmacol Ther 18:521–529PubMedGoogle Scholar
  19. Shattil SJ, Bennett JS, McDonough M, Turnbull J (1980) Carbenicillin and penicillin G inhibit platelet function in vitro by impairing the interaction of agonists with the platelet surface. J Clin Invest 65:329–337PubMedCrossRefGoogle Scholar
  20. Shulman NR, Jordan JV (1987) Platelet Immunology. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Lippincott Philadelphia, (Hemostasis and Thrombosis, pp. 452–529)Google Scholar
  21. Simonsson P, Alling C (1988) The 5-hydroxytryptamine stimulated formation of inositol phosphate is inhibited in platelets of alcoholics. Life Sciences 42:385–391PubMedCrossRefGoogle Scholar
  22. Vanderhoek JY, Feinstein MB (1979) Local anaesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets. Mol Pharmacol 16:171–180PubMedGoogle Scholar
  23. Van Renterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, Deckmyn H, Colucci M, Arnout J, Vermylen J (1985) Thrombembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1:999–1002CrossRefGoogle Scholar
  24. Vermylen J, Blockmans D (1989) Acquired disorders of platelet function. Bailliere’s Clin Haematol 2:729–748CrossRefGoogle Scholar
  25. Vickers A, Guertler J, Spaans C, Tapparelli C, Donatsch P, Fischer V (1987/88) Cyclosporine A nephrotoxicity studied by the combined application of kidney cell lines, hepatocytes, and endothelial-platelet cocultures. Mol Toxicol 1:351–361PubMedGoogle Scholar
  26. Weksler BB (1988) Platelets. In: Gallin JI, Goldstein IM, Snyderman R (eds) Raven Press, New York (Inflammation: Basic Principles and Clinical Correlates, pp. 543–557)Google Scholar
  27. Zagher D, Maaravi Y, Matzner Y, Gilon D, Gotsman MS, Weiss AT (1990) Partial resistance to anticoagulation after streptokinase treatment for acute myocardial infarction. Am J Cardiol 66:28–30CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • K. Schrör
    • 1
  1. 1.Institut für PharmakologieHeinrich-Heine-Universität DüsseldorfDüsseldorf 1Germany

Personalised recommendations